期刊
DRUG DELIVERY AND TRANSLATIONAL RESEARCH
卷 13, 期 7, 页码 1859-1881出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s13346-022-01233-3
关键词
Tolerogenic vaccine; Nanomaterials; Nanoparticles; Autoimmune disease; Allergic disease
Impairment of immune tolerance can lead to autologous tissue damage or excessive immune response against non-pathogenic molecules. Current strategies mainly focus on symptom relief or systemic immunosuppression, which can have fatal adverse events. Inducing antigen-specific immune tolerance may be beneficial for autoimmune diseases and allergies, while minimizing non-specific immune adverse reactions.
Impairment of immune tolerance might cause autologous tissue damage or overactive immune response against non-pathogenic molecules. Although autoimmune disease and allergy have complicated pathologies, the current strategies have mainly focused on symptom amelioration or systemic immunosuppression which can lead to fatal adverse events. The induction of antigen-specific immune tolerance may provide therapeutic benefits to autoimmune disease and allergic response, while reducing nonspecific immune adverse responses. Diverse nanomaterials have been studied to induce antigen-specific immune tolerance therapy. This review will cover the immunological background of antigen-specific tolerance, clinical importance of antigen-specific immune tolerance, and nanomaterials designed for autoimmune and allergic diseases. As nanomaterials for modulating immune tolerances, lipid-based nanoparticles, polymeric nanoparticles, and biological carriers have been covered. Strategies to provide antigen-specific immune tolerance have been addressed. Finally, current challenges and perspectives of nanomaterials for antigen-specific immune tolerance therapy will be discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据